Form 8-K - Current report:
SEC Accession No. 0001520138-22-000509
Filing Date
2022-11-10
Accepted
2022-11-10 17:05:41
Documents
12
Period of Report
2022-11-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT biovie-20221109_8k.htm   iXBRL 8-K 33247
  Complete submission text file 0001520138-22-000509.txt   205920

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bivi-20221109.xsd EX-101.SCH 3239
3 XBRL LABEL FILE bivi-20221109_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bivi-20221109_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT biovie-20221109_8k_htm.xml XML 3599
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 221378394
SIC: 2834 Pharmaceutical Preparations